See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367083_2023_Sonoma_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001367083, Sonoma Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 16,430,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 320,000 |
3 | remainder_Assets | 2,095,000 |
4 | LiabilitiesCurrent | 5,819,000 |
5 | LiabilitiesNoncurrent | 309,000 |
6 | remainder_Liabilities | 4,020,000 |
7 | CostOfGoodsAndServicesSold | 8,635,000 |
8 | SellingGeneralAndAdministrativeExpense | 9,755,000 |
9 | ResearchAndDevelopmentExpense | 125,000 |
10 | remainder_Expenses | -332,000 |
11 | remainder_Revenues | 12,628,000 |
12 | remainder_NetIncome | 469,000 |
13 | remainder_ComprehensiveNetIncome | 267,000 |
yvar | yval | |
---|---|---|
0 | Assets | 18,845,000 |
1 | Liabilities | 10,148,000 |
2 | Expenses | 18,183,000 |
3 | Revenues | 12,628,000 |
4 | StockholdersEquity | 8,697,000 |
5 | NetIncome | -5,086,000 |
6 | ComprehensiveNetIncome | -4,952,500 |
7 | BaseVar | 30,270,000 |
8 | EconomicCapitalRatio | 0.690 |